Cargando…

Introduction

Detalles Bibliográficos
Autor principal:	Owens, Gary M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2013
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437732/ https://www.ncbi.nlm.nih.gov/pubmed/23383727 http://dx.doi.org/10.18553/jmcp.2013.19.s1.S03

Ejemplares similares

Introduction
por: Brixner, Diana I., et al.
Publicado: (2012)

Gender Differences in Health Care Expenditures, Resource Utilization, and Quality of Care
por: Owens, Gary
Publicado: (2008)

Introduction
por: Rumsfeld, John S.
Publicado: (2006)

Introduction
por: Dunn, Jeffrey D.
Publicado: (2012)

Introduction
por: Sax, Michael J.
Publicado: (2005)

Introduction
por: kleinke, J.D., et al.
Publicado: (2005)

Introduction
por: Brixner, Diana I.
Publicado: (2012)

Introduction
por: Minkoff, Neil B., et al.
Publicado: (2005)

Introduction
por: Rodvold, Keith A.
Publicado: (2009)

Introduction
por: Sanoski, Cynthia A.
Publicado: (2009)

Introduction
por: Cosler, Leon E.
Publicado: (2003)

Introduction
por: Sullivan, Sean D., et al.
Publicado: (2003)

Introduction
por: Lipsy, Robert J.
Publicado: (2003)

Introduction
por: Cziraky, Mark J.
Publicado: (2008)

Introduction
por: Chao, Schumarry H.
Publicado: (2006)

Introduction
por: Mullins, C. Daniel, et al.
Publicado: (2011)

Introduction
por: Kamel, Hosam K., et al.
Publicado: (2006)

Introduction: Multiple Myeloma
por: Cook, Richard
Publicado: (2008)

Introduction: Landscape of Opioid Dependence
por: Jan, Saira A.
Publicado: (2010)

Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013)

Introduction: Why Focus on Women and Depression?
por: Keita, Gwendolyn Puryear
Publicado: (2007)

Introduction: Chronic Kidney Disease: A Burgeoning Health Epidemic
por: Peter, Wendy St.
Publicado: (2007)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

Introduction: Targeted Evidenced-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Minkoff, Neil B.
Publicado: (2007)

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)

Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism Introduction
por: Gulseth, Michael P.
Publicado: (2008)

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012)

Epidemiology and Unmet Needs in Hypertension
por: Flack, John M.
Publicado: (2007)

Depression Management in the Workplace
por: Colombi, Alberto M.
Publicado: (2005)

The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
por: File, Thomas M.
Publicado: (2009)

Improving Depression Treatment by Integrated Care
por: Rost, Kathryn M.
Publicado: (2005)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

Potential Advantages of Interprofessional Care in Rheumatoid Arthritis
por: Marion, Carrie Engen, et al.
Publicado: (2011)

Something Old, Something New, Something Borrowed"¦Comparative Effectiveness Research: A Policy Perspective
por: Subedi, Prasun, et al.
Publicado: (2011)

Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis
por: Menzin, Joseph, et al.
Publicado: (2013)

Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
por: Foley, John F., et al.
Publicado: (2013)

Evidence for Long-Term Use of Intramuscular Interferon Beta-1a: An Overview of Relapse, Disability, and MRI Data from Selected Clinical Trials
por: Foley, John F., et al.
Publicado: (2013)

Part1 How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_s6lm1qavba5ftumhn457gpd5bc